Abstract
No public abstract is available from the verified source records.
Chikashi Iwasaki, Eisaku Miyauchi, Takaya Yamamoto, Hisashi Tanaka, Yasuhito Nunomura, Yoshiomi Hatayama, Ryo Morita, Shin Fukui, Tatsunori Ito, Yoko Tsukita, Risa Ebina-Shibuya, Hisatoshi Sugiura
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship
10.1016/s0025-6196(11)60735-0 · 2008
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer
10.1200/jco.2009.26.2543 · 2010
10.1016/j.jtho.2015.09.009
10.1016/j.jtho.2015.09.009 · 2016
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO clinical Practice Guidelines for diagnosis, treatment and follow-up
10.1093/annonc/mdx222 · 2017
PACIFIC investigators, durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer
10.1056/nejmoa1709937 · 2017
Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer
10.1200/jco.21.01308 · 2022
Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
10.1093/ejcts/ezs065 · 2012
Survival after resection for primary lung cancer: a population based study of 3211 resected patients
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.1136/thx.2005.056481 · 2006
Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy
10.3892/mco.2015.509 · 2015
Deciphering the clinical features of heterogeneous stage III non-small cell lung cancer in Japanese real-world clinical practice: expanded cohort of the SOLUTION study
10.1016/j.lungcan.2021.12.005 · 2022
Effect of radiation therapy techniques on outcome in N3-positive IIIB non-small cell lung cancer treated with concurrent chemoradiotherapy
10.4143/crt.2014.131 · 2016
Lower lobe origin is related to unfavorable outcomes in patients with stage I–III lung cancer treated with radical chemoradiotherapy
10.1177/0300891620971359 · 2021
Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy
10.1016/s0360-3016(02)02803-1 · 2002
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
10.1016/s0360-3016(99)00183-2 · 1999
Direct lymphatic drainage of lung segments to the mediastinal nodes. An anatomic study on 260 adults
10.1016/s0022-5223(19)34555-6 · 1989
PACIFIC investigators, overall survival with durvalumab after chemoradiotherapy in Stage III NSCLC
10.1056/nejmoa1809697 · 2018
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
10.1016/j.ejca.2008.10.026 · 2009
The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
10.1016/s0140-6736(07)61602-x · 2007
Poor prognosis of NSCLC located in lower lobe is partly mediated by lower frequency of EGFR mutations
2020
Radiomics: extracting more information from medical images using advanced feature analysis
10.1016/j.ejca.2011.11.036 · 2012
Prognostic value of metabolic tumor volume on [18F]FDG PET/CT in addition to the TNM classification system of locally advanced non-small cell lung cancer
10.1186/s40644-024-00811-7 · 2024
Imaging heterogeneity in lung cancer: techniques, applications, and challenges
10.2214/ajr.15.15864 · 2016
Radiomics in oncological PET/CT: a methodological overview
10.1007/s13139-019-00571-4 · 2019
Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis
10.1016/j.athoracsur.2004.06.081 · 2005
Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer
10.1016/j.ijrobp.2006.12.066 · 2007
Novel biologic factors correlated to visceral pleural invasion in early-stage non-small cell lung cancer less than 3 cm
10.21037/jtd.2018.03.185 · 2018
Pleural tags on CT scans to predict visceral pleural invasion of non-small cell lung cancer that does not abut the pleura
10.1148/radiol.2015151120 · 2016
Lobectomy is the preferred choice rather than sublobar resection for centrally located clinical stage 1 non-small cell lung cancer
10.1093/ejcts/ezaf233 · 2025
No additional external references are available.